CERT Certara Inc

USD 16.58 0.50 3.109453
Icon

Certara Inc (CERT) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 16.58

+0.50 (+3.11)%

USD 2.23B

0.57M

USD 18.81(+13.47%)

USD 23.00 (+38.72%)

Icon

CERT

Certara Inc (USD)
COMMON STOCK | NSD
USD 16.58
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.23B

USD 23.00 (+38.72%)

USD 16.58

Certara Inc (CERT) Stock Forecast

Show ratings and price targets of :
USD 18.81
(+13.47%)

Based on the Certara Inc stock forecast from 6 analysts, the average analyst target price for Certara Inc is USD 18.81 over the next 12 months. Certara Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Certara Inc is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Certara Inc’s stock price was USD 16.58. Certara Inc’s stock price has changed by +5.94% over the past week, +21.55% over the past month and -14.45% over the last year.

No recent analyst target price found for Certara Inc
No recent average analyst rating found for Certara Inc

Company Overview Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It of...Read More

https://www.certara.com

100 Overlook Center, Princeton, NJ, United States, 08540

1,338

December

USD

USA

Adjusted Closing Price for Certara Inc (CERT)

Loading...

Unadjusted Closing Price for Certara Inc (CERT)

Loading...

Share Trading Volume for Certara Inc Shares

Loading...

Compare Performance of Certara Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CERT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Certara Inc (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GEHC
GE HealthCare Technologies Inc.. +0.79 (+0.98%) USD36.72B 23.38 13.30

ETFs Containing CERT

Symbol Name CERT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Certara Inc (CERT) Stock

Based on ratings from 6 analysts Certara Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 6 hold ratings.

Unfortunately we do not have enough data on CERT's stock to indicate if its a good dividend stock.

Based on targets from 6 analysts, the average taret price for CERT is USD 18.81 over the next 12 months. The maximum analyst target price is USD 23 while the minimum anlayst target price is USD 15.5.

CERT stock's Price/Earning ratio is 108.50. Our analysis grades CERT stock's Price / Earning ratio at F. This means that CERT stock's Price/Earning ratio is above 69% of the stocks in the Health Information Services sector in the NSD exchange. Based on this CERT may be a overvalued for its sector.

The last closing price of CERT's stock was USD 16.58.

The most recent market capitalization for CERT is USD 2.23B.

Based on targets from 6 analysts, the average taret price for CERT is projected at USD 18.81 over the next 12 months. This means that CERT's stock price may go up by +13.47% over the next 12 months.

We can't find any ETFs which contains Certara Inc's stock.

As per our most recent records Certara Inc has 1,338 Employees.

Certara Inc's registered address is 100 Overlook Center, Princeton, NJ, United States, 08540. You can get more information about it from Certara Inc's website at https://www.certara.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...